Shandong New Time Pharmaceutical Co., Ltd., commonly referred to as New Time Pharma, is a leading player in the pharmaceutical industry, headquartered in Shandong, China. Established in 2003, the company has rapidly expanded its operations across various regions, focusing on the development and manufacturing of high-quality pharmaceutical products. Specialising in active pharmaceutical ingredients (APIs) and finished dosage forms, New Time Pharma is renowned for its commitment to innovation and quality. The company’s core offerings include a diverse range of generic medications and specialty pharmaceuticals, distinguished by their efficacy and safety profiles. With a strong market presence, Shandong New Time Pharmaceutical has achieved significant milestones, including certifications from international regulatory bodies, which underscore its dedication to maintaining the highest industry standards. As a trusted partner in healthcare, New Time Pharma continues to contribute to global health advancements through its cutting-edge solutions.
How does Shandong New Time Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Shandong New Time Pharmaceutical Co., Ltd.'s score of 10 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Shandong New Time Pharmaceutical Co., Ltd., headquartered in CN, currently does not have available carbon emissions data for recent years, as no specific figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions figures to analyse. In the absence of concrete emissions data, it is important to note that the company has not outlined any specific reduction targets or climate commitments. This lack of information suggests that Shandong New Time Pharmaceutical may still be in the early stages of developing a comprehensive climate strategy or may not have publicly disclosed their initiatives. As the pharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Shandong New Time Pharmaceutical to establish clear climate commitments and reduction targets to align with global efforts to mitigate climate change.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shandong New Time Pharmaceutical Co., Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.